201 related articles for article (PubMed ID: 22431471)
1. Antibiotic treatment of children with community-acquired pneumonia: comparison of penicillin or ampicillin versus cefuroxime.
Dinur-Schejter Y; Cohen-Cymberknoh M; Tenenbaum A; Brooks R; Averbuch D; Kharasch S; Kerem E
Pediatr Pulmonol; 2013 Jan; 48(1):52-8. PubMed ID: 22431471
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy.
Breuer O; Blich O; Cohen-Cymberknoh M; Averbuch D; Kharasch S; Shoseyov D; Kerem E
Pediatr Pulmonol; 2015 May; 50(5):495-502. PubMed ID: 25652187
[TBL] [Abstract][Full Text] [Related]
3. IV Penicillin G is as effective as IV cefuroxime in treating community-acquired pneumonia in children.
Amarilyo G; Glatstein M; Alper A; Scolnik D; Lavie M; Schneebaum N; Grisaru-Soen G; Assia A; Ben-Sira L; Reif S
Am J Ther; 2014; 21(2):81-4. PubMed ID: 22407197
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of health care-associated pneumonia empirically treated with guideline-concordant regimens versus community-acquired pneumonia guideline-concordant regimens for patients admitted to acute care wards from home.
Chen JI; Slater LN; Kurdgelashvili G; Husain KO; Gentry CA
Ann Pharmacother; 2013 Jan; 47(1):9-19. PubMed ID: 23324506
[TBL] [Abstract][Full Text] [Related]
5. Impact of a guideline on management of children hospitalized with community-acquired pneumonia.
Newman RE; Hedican EB; Herigon JC; Williams DD; Williams AR; Newland JG
Pediatrics; 2012 Mar; 129(3):e597-604. PubMed ID: 22351891
[TBL] [Abstract][Full Text] [Related]
6. Comparative efficacy of amoxicillin, cefuroxime and clarithromycin in the treatment of community -acquired pneumonia in children.
Aurangzeb B; Hameed A
J Coll Physicians Surg Pak; 2003 Dec; 13(12):704-7. PubMed ID: 15569557
[TBL] [Abstract][Full Text] [Related]
7. A comparison of levofloxacin and moxifloxacin use in hospitalized community-acquired pneumonia (CAP) patients in the US: focus on length of stay.
Schein J; Janagap-Benson C; Grant R; Sikirica V; Doshi D; Olson W
Curr Med Res Opin; 2008 Mar; 24(3):895-906. PubMed ID: 18419876
[TBL] [Abstract][Full Text] [Related]
8. Intravenous penicillin--still the first-line therapy for pediatric community-acquired pneumonia.
Korppi M
Pediatr Pulmonol; 2013 Apr; 48(4):408-9. PubMed ID: 22778061
[No Abstract] [Full Text] [Related]
9. Antibiotic utilization and cost analysis in hospitalized patients with community-acquired pneumonia.
Stein GE; Mantz SL
Hosp Pharm; 1995 Feb; 30(2):132-4, 137. PubMed ID: 10140526
[TBL] [Abstract][Full Text] [Related]
10. Antibiotics for community-acquired pneumonia in children.
Lodha R; Kabra SK; Pandey RM
Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD004874. PubMed ID: 23733365
[TBL] [Abstract][Full Text] [Related]
11. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
[TBL] [Abstract][Full Text] [Related]
12. Comparative randomized trial of azithromycin versus erythromycin and amoxicillin for treatment of community-acquired pneumonia in children.
Kogan R; Martínez MA; Rubilar L; Payá E; Quevedo I; Puppo H; Girardi G; Castro-Rodriguez JA
Pediatr Pulmonol; 2003 Feb; 35(2):91-8. PubMed ID: 12526069
[TBL] [Abstract][Full Text] [Related]
13. Empiric antibiotic therapy in children with community-acquired pneumonia.
Zhang L; Lovatel R; Nicolete D; Sinzkel E; Matiello J; Staszko K; Lincho C
Indian Pediatr; 2008 Jul; 45(7):554-8. PubMed ID: 18695273
[TBL] [Abstract][Full Text] [Related]
14. Cefuroxime for empiric treatment of community-acquired pneumococcal pneumonia: is there a generation gap?
Wiener-Well Y; Raveh D; Schlesinger Y; Yinnon AM; Rudensky B
Chemotherapy; 2009; 55(2):97-104. PubMed ID: 19145079
[TBL] [Abstract][Full Text] [Related]
15. Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia--a propensity-adjusted analysis.
Choudhury G; Mandal P; Singanayagam A; Akram AR; Chalmers JD; Hill AT
Clin Microbiol Infect; 2011 Dec; 17(12):1852-8. PubMed ID: 21919994
[TBL] [Abstract][Full Text] [Related]
16. Chloramphenicol versus ampicillin plus gentamicin for community acquired very severe pneumonia among children aged 2-59 months in low resource settings: multicentre randomised controlled trial (SPEAR study).
Asghar R; Banajeh S; Egas J; Hibberd P; Iqbal I; Katep-Bwalya M; Kundi Z; Law P; MacLeod W; Maulen-Radovan I; Mino G; Saha S; Sempertegui F; Simon J; Santosham M; Singhi S; Thea DM; Qazi S;
BMJ; 2008 Jan; 336(7635):80-4. PubMed ID: 18182412
[TBL] [Abstract][Full Text] [Related]
17. Comparative effectiveness of empiric β-lactam monotherapy and β-lactam-macrolide combination therapy in children hospitalized with community-acquired pneumonia.
Ambroggio L; Taylor JA; Tabb LP; Newschaffer CJ; Evans AA; Shah SS
J Pediatr; 2012 Dec; 161(6):1097-103. PubMed ID: 22901738
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of childhood pneumonia.
Nascimento-Carvalho CM
Expert Opin Pharmacother; 2010 Feb; 11(2):225-31. PubMed ID: 20088744
[TBL] [Abstract][Full Text] [Related]
19. A cost-effectiveness analysis of antimicrobial treatment of community-acquired pneumonia taking into account resistance in Belgium.
Martin M; Moore L; Quilici S; Decramer M; Simoens S
Curr Med Res Opin; 2008 Mar; 24(3):737-51. PubMed ID: 18230196
[TBL] [Abstract][Full Text] [Related]
20. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
